BioSpace News Archive

edShape, Inc., the industry leader in orthopedic devices using advanced functional materials, announced today the full market release of the DynaNail Mini® Fusion System for medial column fusion to address Charcot Foot and other severe midfoot conditions

-T1Detect makes T1D screening easier and more accessible with unrestricted eligibility requirements for at-home testing and financial assistance-

As COVID-19 continues to spread across the United States and vaccine distribution begins, the National Pharmacy Technician Association (NPTA), a leading provider of ACPE-accredited continuing education and advanced training programs for certified pharmacy technicians, is announcing the launch of a nationally-recognized pharmacy technician administered immunization training program

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 10th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021.

Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) and SōRSE Technology Corporation (“SōRSE”) have validated and optimized a formula for oral cannabinoid delivery

Operations Management Veteran Robert Sullivan Brings Over 30 Years of Experience to Bio-Pharmaceutical Startup

Bluejay Diagnostics, Inc. (Bluejay, Acton, MA ) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan ) to develop a minimally-invasive, point-of-care test for COV

Caris’ AI-powered predictor helps gauge which metastatic colorectal cancer patients will benefit from treatment with current standard of care regimen Exploratory analyses also found benefit in advanced esophageal/gastro-esophageal junction cancers and pancreatic ductal adenocarcinoma

Skinopathy, a new Canadian medical technology start-up, is developing Artificial Intelligence technology to help fight the scourge of skin cancer.

Carlsmed, Inc., today announced it has been granted 510(k) clearance and Breakthrough Device Designation by the FDA for its aprevo patient specific interbody devices for the correction of adult spinal deformity. The Carlsmed aprevo device is the first implant ever to receive both Breakthrough Device Designation and 510(k) market clearance from the FDA. To meet t